I read with interest the article by Lu and colleagues1 which shows that quality indicators of
pharmacotherapy are associated with increased odds of admission to hospital, but reduced …

There is no doubt about the current pandemic of obesity and its diverse consequences for
health. The list of complications is long, particularly the increase in the incidence of Type 2 …

Centers for Disease Control and Prevention (CDC) defines the problem as weight that is
higher than what is healthy for a given height, with quantitative definitions of overweight and …

There is a growing unmet need for more effective treatment of obesity and its complications.
While current anti-obesity medications are effective and offer real clinical benefits over diet …

I read with interest the article by Lu and colleagues1 which shows that quality indicators of
pharmacotherapy are associated with increased odds of admission to hospital, but reduced …

There was awareness of the dangers of obesity some four centuries ago, yet even today the
weight of our population continues its relentless expansion despite improved health care in …

Recent publicity around the use of new antiobesity medications (AOMs) has focused the
attention of patients and healthcare providers on the role of pharmacotherapy in the …

We do not believe the article 'Medicines for long-term obesity management'1 is consistent
with the NPS MedicineWise philosophy, to provide independent and evidence-based advice …

Background To report the trends in the use and costs of anti-obesity medications in England
from 1998 to 2005. Methods We analysed data on all community anti-obesity drug …

Obesity is the largest public health threat, affecting 42.4% of US adults. 1 In this issue of
Mayo Clinic Proceedings, Claridy et al 2 report that although there have been minor …